• Wondering whether Clorox at around US$92 per share is a bargain or a value trap, this article focuses on what the current price might be implying about the stock's value.
• The stock is down 4.5% over the last week, 10.6% over the past month, and 30.1% over the last year. This may have changed how the market views its risk and return trade off.
• Recent coverage has centered on how Clorox is handling shifting consumer demand, cost pressures, and competitive intensity in household products. All of these factors help explain why sentiment has been weak. Other news has focused on how the company is positioning its brands and operations, which can influence how investors think about its resilience and pricing power.
• Clorox scores 5 out of 6 on Simply Wall St's valuation checks, and you can see the full breakdown in the valuation score. Next up is a closer look at traditional valuation approaches and an even deeper way to think about what the current price could mean for long term value.

Approach 1: Clorox Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting the company’s future cash flows and discounting them back to today’s value. It is essentially asking what all those future dollars are worth in $ right now.

For Clorox, Simply Wall St uses a 2 Stage Free Cash Flow to Equity model. The latest twelve month Free Cash Flow is about $370.8 million. Analyst estimates and extrapolated figures point to Free Cash Flow of around $997.7 million in 2035, with intermediate projections such as $757.9 million in 2026 and $851.8 million in 2027. These longer dated numbers blend analyst inputs for the next few years with Simply Wall St’s own extrapolations beyond that.

When all those projected cash flows are discounted back, the model arrives at an estimated intrinsic value of about $171.14 per share, in $ terms. Compared to a recent share price around $92, the DCF output suggests the stock trades at an implied 46.2% discount, which the model characterizes as indicating upside potential if the cash flow path occurs as projected.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Clorox is undervalued by 46.2%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Clorox Price vs Earnings

For profitable companies, the P/E ratio is a useful shorthand because it links what you pay for each share to the earnings that the business is already generating. It gives you a quick sense of how much the market is willing to pay for each dollar of current earnings.

What counts as a "normal" P/E ratio often reflects investors’ expectations for future growth and the risk they see in those earnings. Higher expected growth or lower perceived risk can justify a higher multiple, while slower expected growth or higher risk usually lines up with a lower one.

Clorox currently trades on a P/E of 14.7x. That sits below both the Household Products industry average of about 18.0x and the broader peer group average of 24.7x. Simply Wall St’s Fair Ratio for Clorox is 17.2x, which is its estimate of an appropriate P/E once factors such as earnings growth profile, industry, profit margins, market cap and key risks are taken into account.

This Fair Ratio can be more useful than a simple industry or peer comparison because it is tailored to Clorox’s own characteristics rather than relying on headline averages. With the current 14.7x P/E sitting below the 17.2x Fair Ratio, the multiple indicates that the stock appears undervalued on this measure.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Clorox Narrative

Earlier we mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you turn your view on Clorox into a clear story that links its business drivers to a financial forecast and then to a Fair Value. You can compare this with the current share price to help decide whether to act now or wait.

In practice, a Narrative is your version of that story. You set assumptions for Clorox’s future revenue, earnings, margins and the multiple you think is reasonable, and the platform converts that into a Fair Value that updates automatically when new news or earnings arrive, so your view does not go stale.

On the Simply Wall St Community page, you can see how different investors interpret the same information. For example, a more cautious Clorox Narrative might anchor around a Fair Value close to US$94.0, while a more optimistic view could sit near US$159.82. This shows how the same stock can look very different once you attach a story to the numbers.

Do you think there's more to the story for Clorox? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.